A method for detecting, screening and/or monitoring a cancer in an individual
CA 2500232 A1 · Owner: Malling, Jesper · Inventors: Holten-Andersen, Mads; Bruenner, Nils; Malling, Jesper
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The invention relates to a method for screening and/or detecting and/or monitoring a cancer in an individual, said method comprising determining a first parameter represented by the concentration of TIMP-1 in at least one excreta, e.g. saliva, from the individual. The invention provides a method that without the need to use a blood sample is suitable for facilitating the early diagnosis of a cancer, monitoring the recurrence of a cancer and/or , monitoring the status of a cancer or the effect of cancer treatment in an individual.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed September 26, 2003. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended September 26, 2023.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by September 26, 2025.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.